Ideeea Therapeutics is a biotech venture that develops and manufactures groundbreaking, ready-to-use advanced therapy medicinal products (ATMPs) in the fields of regenerative and autoimmune medicine. Ideeea Therapeutics’ first project is AGAcell, the first preclinical research program exploring an allogeneic therapy with mesenchymal stem cells for androgenetic alopecia (AGA).

Krieen has been entrusted with creating Ideeea’s global brand umbrella, including brand strategy and positioning, company name, corporate identity, website, manifest video and communications. We also led the launch of AGAcell, including the positioning, an explainer video, a PR campaign and content creation.

The name “Ideeea Therapeutics” capitalizes on the venture’s most valuable skill: developing unique ideas with huge growth potential in the crowded biotech industry. Its 3 e’s make the name striking and memorable and are connected to the initial brand positioning: “Enlightening Advanced Therapies”.

The brand essence "Enlightening", along with the tagline "Enlightening Advanced Therapies. Enlightening Hope", represents Ideeea Therapeutics' mission: developing big ideas in the biotech industry that turn into cutting-edge therapies for millions of people.

In order to introduce AGAcell to HCPs, media and investors, we created an explainer video and a product visual among other materials to make this pioneering biotech project easy-to-understand in the blink of an eye.

The light beam is the key visual for the brand, serving as the leitmotif in the video explaining insights for patients and current treatment challenges, giving an overview of the product idea and manufacturing process as well as the benefits for the patient.

Alex Krieger (Krieen) and Marisa Berenguer (CEO, Co-Founder & Board Member at Ideeea Therapeutics and Farmalider)